PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Authors
Keywords
-
Journal
ACTA NEUROPATHOLOGICA
Volume 139, Issue 6, Pages 1025-1044
Publisher
Springer Science and Business Media LLC
Online
2020-03-13
DOI
10.1007/s00401-020-02138-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
- (2019) Marc Suárez-Calvet et al. Molecular Neurodegeneration
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease
- (2019) Maria Carolina Dalmasso et al. Translational Psychiatry
- Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
- (2019) Lorenza Magno et al. Alzheimers Research & Therapy
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
- (2019) Brian W. Kunkle et al. NATURE GENETICS
- Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- (2019) Henriette Haukedal et al. JOURNAL OF MOLECULAR BIOLOGY
- Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
- (2019) Ilie-Cosmin Stancu et al. ACTA NEUROPATHOLOGICA
- A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
- (2019) Sven J. van der Lee et al. ACTA NEUROPATHOLOGICA
- Immune Signaling in Neurodegeneration
- (2019) Timothy R. Hammond et al. IMMUNITY
- Single-cell transcriptomic analysis of Alzheimer’s disease
- (2019) Hansruedi Mathys et al. NATURE
- WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
- (2019) Yuxing Liao et al. NUCLEIC ACIDS RESEARCH
- Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease
- (2019) Michael G. Heckman et al. MOVEMENT DISORDERS
- GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
- (2019) Arvid Rongve et al. Scientific Reports
- NLRP3 inflammasome activation drives tau pathology
- (2019) Christina Ising et al. NATURE
- Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
- (2019) Joseph F. Arboleda-Velasquez et al. NATURE MEDICINE
- Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model
- (2019) Elizabeth Spangenberg et al. Nature Communications
- Longitudinal transcriptomic analysis of altered pathways in a CHMP2Bintron5-based model of ALS-FTD
- (2019) Robin Waegaert et al. NEUROBIOLOGY OF DISEASE
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
- (2018) Aleksandra Deczkowska et al. CELL
- Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
- (2018) Wilbur M. Song et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
- (2018) Justyna Sosna et al. Molecular Neurodegeneration
- Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models
- (2018) C.Y. Daniel Lee et al. NEURON
- Statistical tests and identifiability conditions for pooling and analyzing multisite datasets
- (2018) Hao Henry Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models
- (2018) Brad A. Friedman et al. Cell Reports
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
- (2018) Rosebud O. Roberts et al. JAMA Neurology
- Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality
- (2018) Shabina A. Hayat et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
- (2018) Ione O. C. Woollacott et al. Alzheimers Research & Therapy
- ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
- (2018) Olivia J Conway et al. Molecular Neurodegeneration
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum
- (2018) Boris-Stephan Rauchmann et al. NEUROBIOLOGY OF AGING
- By Capturing Inflammatory Lipids Released from Dying Cells, the Receptor CD14 Induces Inflammasome-Dependent Phagocyte Hyperactivation
- (2017) Ivan Zanoni et al. IMMUNITY
- Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
- (2017) Deepti Lall et al. JOURNAL OF CLINICAL INVESTIGATION
- Estimation of Extended Mixed Models Using Latent Classes and Latent Processes: The R Package lcmm
- (2017) Cécile Proust-Lima et al. Journal of Statistical Software
- TREM2 in Neurodegenerative Diseases
- (2017) Taylor R. Jay et al. Molecular Neurodegeneration
- Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
- (2017) Carmen Venegas et al. NATURE
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
- (2017) Rebecca Sims et al. NATURE GENETICS
- Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline
- (2017) Timothy J. Hohman et al. NEUROBIOLOGY OF AGING
- The druggable genome and support for target identification and validation in drug development
- (2017) Chris Finan et al. Science Translational Medicine
- Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology
- (2016) Adrian Olmos-Alonso et al. BRAIN
- Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology
- (2016) Elizabeth E. Spangenberg et al. BRAIN
- Nonsingular subsampling for regression S estimators with categorical predictors
- (2016) Manuel Koller et al. COMPUTATIONAL STATISTICS
- Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases
- (2016) Raffaele Ferrari et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
- (2016) A Lacour et al. MOLECULAR PSYCHIATRY
- Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
- (2016) Carla Abdelnour et al. MOVEMENT DISORDERS
- TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
- (2016) Felix L. Yeh et al. NEURON
- Complement and microglia mediate early synapse loss in Alzheimer mouse models
- (2016) S. Hong et al. SCIENCE
- The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
- (2015) Christina M. Lill et al. Alzheimers & Dementia
- Convergent genetic and expression data implicate immunity in Alzheimer's disease
- (2015) Lesley Jones et al. Alzheimers & Dementia
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice
- (2015) Nabil N. Dagher et al. Journal of Neuroinflammation
- A novel Alzheimer disease locus located near the gene encoding tau protein
- (2015) G Jun et al. MOLECULAR PSYCHIATRY
- Depletion of microglia and inhibition of exosome synthesis halt tau propagation
- (2015) Hirohide Asai et al. NATURE NEUROSCIENCE
- Brief Report: Connecting Two Pathways Through Ca2+Signaling: NLRP3 Inflammasome Activation Induced by a HypermorphicPLCG2Mutation
- (2015) Jae Jin Chae et al. Arthritis & Rheumatology
- What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus
- (2014) Anders M. Fjell et al. PROGRESS IN NEUROBIOLOGY
- Much of late life cognitive decline is not due to common neurodegenerative pathologies
- (2013) Patricia A. Boyle et al. ANNALS OF NEUROLOGY
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Classification and Epidemiology of MCI
- (2013) Rosebud Roberts et al. CLINICS IN GERIATRIC MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
- (2013) Sruti Rayaprolu et al. Molecular Neurodegeneration
- Human genetics as a foundation for innovative drug development
- (2013) Alexander Kamb et al. NATURE BIOTECHNOLOGY
- Validating therapeutic targets through human genetics
- (2013) Robert M. Plenge et al. NATURE REVIEWS DRUG DISCOVERY
- Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration
- (2013) William Jagust NEURON
- Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia–like Syndrome Without Bone Involvement
- (2013) Rita João Guerreiro et al. JAMA Neurology
- The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials
- (2012) Nandini Raghavan et al. Alzheimers & Dementia
- GeneFriends: An online co-expression analysis tool to identify novel gene targets for aging and complex diseases
- (2012) Sipko van Dam et al. BMC GENOMICS
- Cold Urticaria, Immunodeficiency, and Autoimmunity Related toPLCG2Deletions
- (2012) Michael J. Ombrello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Misuse of the Linear Mixed Model When Evaluating Risk Factors of Cognitive Decline
- (2011) C. Proust-Lima et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
- (2011) Ivan Zanoni et al. CELL
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Reimagining Alzheimer's Disease--An Age-Based Hypothesis
- (2010) K. Herrup JOURNAL OF NEUROSCIENCE
- Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models
- (2010) Simon N. Wood JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Regulation of Tau Pathology by the Microglial Fractalkine Receptor
- (2010) Kiran Bhaskar et al. NEURON
- TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
- (2010) Q. Peng et al. Science Signaling
- Expression of amyloid beta peptide in human platelets: Pivotal role of the phospholipase Cγ2-protein kinase C pathway in platelet activation
- (2008) Ming-Yi Shen et al. PHARMACOLOGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now